ARG1 and plasma cell myeloma: Thus, MDSCs in lymphoma [59,60,61,62] and multiple myeloma [63,64] patients were correlated with an upregulated gene expression of ARG-1 and iNOS, and increased expression of ARG-1 in PMN-MDSCs was associated with the disease progression and the resistance to therapy [65].